ATE429440T1 - Formen prostataspezifischer antigene und verfahren zu deren nachweis - Google Patents
Formen prostataspezifischer antigene und verfahren zu deren nachweisInfo
- Publication number
- ATE429440T1 ATE429440T1 AT02750561T AT02750561T ATE429440T1 AT E429440 T1 ATE429440 T1 AT E429440T1 AT 02750561 T AT02750561 T AT 02750561T AT 02750561 T AT02750561 T AT 02750561T AT E429440 T1 ATE429440 T1 AT E429440T1
- Authority
- AT
- Austria
- Prior art keywords
- prostate
- forms
- detection
- specific antigens
- ppsa
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/40—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against enzymes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
- C12Y304/21—Serine endopeptidases (3.4.21)
- C12Y304/21077—Semenogelase (3.4.21.77), i.e. prostate specific antigen or PSA or kallikrein 3
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
- C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
- C12N9/6424—Serine endopeptidases (3.4.21)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
- C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
- C12N9/6424—Serine endopeptidases (3.4.21)
- C12N9/6445—Kallikreins (3.4.21.34; 3.4.21.35)
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57407—Specifically defined cancers
- G01N33/57434—Specifically defined cancers of prostate
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Biomedical Technology (AREA)
- General Health & Medical Sciences (AREA)
- Wood Science & Technology (AREA)
- Molecular Biology (AREA)
- Zoology (AREA)
- Biochemistry (AREA)
- Immunology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Food Science & Technology (AREA)
- Oncology (AREA)
- Cell Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Hospice & Palliative Care (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/792,692 US7288636B2 (en) | 1997-04-30 | 2001-02-23 | Forms of prostate specific antigens and methods for their detection |
PCT/US2002/005424 WO2002072752A2 (en) | 2001-02-23 | 2002-02-22 | Forms of prostate specific antigens and methods for their detection |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE429440T1 true ATE429440T1 (de) | 2009-05-15 |
Family
ID=25157751
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT02750561T ATE429440T1 (de) | 2001-02-23 | 2002-02-22 | Formen prostataspezifischer antigene und verfahren zu deren nachweis |
Country Status (7)
Country | Link |
---|---|
US (1) | US7288636B2 (de) |
EP (1) | EP1392719B1 (de) |
AT (1) | ATE429440T1 (de) |
AU (1) | AU2002306568A1 (de) |
DE (1) | DE60232069D1 (de) |
ES (1) | ES2324601T3 (de) |
WO (1) | WO2002072752A2 (de) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7659073B2 (en) | 1997-04-30 | 2010-02-09 | Hybritech Incorporated | Forms of prostate specific antigens and methods for their detection |
US20090087860A1 (en) * | 2007-08-24 | 2009-04-02 | Todd John A | Highly sensitive system and methods for analysis of prostate specific antigen (psa) |
WO2012006634A2 (en) * | 2010-07-09 | 2012-01-12 | The Board Of Trustees Of The University Of Illiniois | Prostate specific antigen (psa) peptide therapy |
US8557777B2 (en) | 2010-07-09 | 2013-10-15 | The Board Of Trustees Of The University Of Illinois | Methods for treating cancer using prostate specific antigen and tumor endothelial marker peptides |
EP2619588B1 (de) * | 2010-09-23 | 2019-08-07 | Biocept, Inc. | Verfahren und reagenzien zur verstärkung von signalen |
KR20200075023A (ko) | 2012-05-04 | 2020-06-25 | 화이자 인코포레이티드 | 전립선 관련된 항원 및 백신 기재 면역치료 요법 |
CN105929151A (zh) * | 2016-06-30 | 2016-09-07 | 深圳市亚辉龙生物科技股份有限公司 | ***特异性抗原同源异构体化学发光免疫检测试剂盒及其制备方法 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE9002480D0 (sv) * | 1990-07-23 | 1990-07-23 | Hans Lilja | Assay of free and complexed prostate-specific antigen |
JPH08502889A (ja) | 1992-10-29 | 1996-04-02 | トーマス・ジェファーソン・ユニバーシティ | 前立腺癌の微小転移を検出する方法 |
US6103237A (en) | 1993-07-22 | 2000-08-15 | Hybritech Incorporated | Stable variant hK2 polypeptide |
US5599677A (en) * | 1993-12-29 | 1997-02-04 | Abbott Laboratories | Immunoassays for prostate specific antigen |
EP0725139A3 (de) | 1995-02-03 | 1997-11-26 | Bayer Corporation | Rekombinantes prostat-spezifisches Antigen und seiner Verwendung als Immunoassay-Kalibrator |
ATE404676T1 (de) | 1997-04-30 | 2008-08-15 | Hybritech Inc | Prostat-spezifisches-antigenformen und verfahren zu ihrer bestimmung |
US7674275B2 (en) | 2006-10-05 | 2010-03-09 | Ethicon Endo-Surgery, Inc. | Suture anchor |
-
2001
- 2001-02-23 US US09/792,692 patent/US7288636B2/en not_active Expired - Fee Related
-
2002
- 2002-02-22 WO PCT/US2002/005424 patent/WO2002072752A2/en active Search and Examination
- 2002-02-22 AT AT02750561T patent/ATE429440T1/de not_active IP Right Cessation
- 2002-02-22 ES ES02750561T patent/ES2324601T3/es not_active Expired - Lifetime
- 2002-02-22 AU AU2002306568A patent/AU2002306568A1/en not_active Abandoned
- 2002-02-22 EP EP02750561A patent/EP1392719B1/de not_active Expired - Lifetime
- 2002-02-22 DE DE60232069T patent/DE60232069D1/de not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
EP1392719A4 (de) | 2005-10-19 |
ES2324601T3 (es) | 2009-08-11 |
DE60232069D1 (de) | 2009-06-04 |
AU2002306568A1 (en) | 2002-09-24 |
EP1392719A2 (de) | 2004-03-03 |
US7288636B2 (en) | 2007-10-30 |
EP1392719B1 (de) | 2009-04-22 |
WO2002072752A3 (en) | 2003-02-27 |
WO2002072752A2 (en) | 2002-09-19 |
US20020058291A1 (en) | 2002-05-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1077602A1 (en) | Use of nucleic acids in preparation of a diagnostic agent for evaluating a disease condition in a patient | |
WO2005010213A3 (en) | Markers for detection of gastric cancer | |
HUP9701717A2 (hu) | Eljárás cPSA-meghatározására | |
PT1157041E (pt) | Anticorpos para terapia e diagnostico de cancro | |
WO2002031507A3 (en) | Non-invasive enzyme screen for tissue remodelling-associated conditions | |
WO2006039405A3 (en) | Drug screening and molecular diagnostic test for early detection of colorectal cancer: reagents, methods and kits thereof | |
AU5502101A (en) | Cancer diagnosis method | |
BRPI0411200A (pt) | método de tratamento de cáncer, métodos de tratamento de paciente humano, artigo industrializado e kit de tratamento de cáncer | |
EP1855719A4 (de) | Neutralisierende monoklonale antikörper gegen coronaviren in zusammenhang mit schwerem akutem atemwegssyndrom | |
SI1535068T1 (sl) | Naprave in postopki za odkrivanje amnijske tekočine v vaginalnih izločkih | |
DE60129151D1 (de) | Verfahren zur erkennung von eierstockkrebs mittels menschlichem kallikrein (hk6) | |
WO2011082345A3 (en) | Compositions and methods for cancer management using antibodies binding to nucleotide salvage pathway enzymes and complexes thereof | |
WO2005040421A3 (en) | Prognostic and diagnostic markers for cell proliferative disorders of the breast tissues | |
ATE429440T1 (de) | Formen prostataspezifischer antigene und verfahren zu deren nachweis | |
AU2002315411A1 (en) | Detection and treatment of prostate cancer | |
ATE404676T1 (de) | Prostat-spezifisches-antigenformen und verfahren zu ihrer bestimmung | |
WO2005069935A3 (en) | METHODS FOR MEASURING TRANSFORMING GROWTH FACTOR BETA (TGF-β) RECEPTOR SIGNALING ACTIVITY AND USES THEREOF | |
ATE445839T1 (de) | Latentes tuberkulose-diagnostisches antigen und verwendungsmethode | |
CA2366514A1 (en) | Diagnostic and therapeutic use of antibodies against the urokinase receptor | |
EP1572225A4 (de) | Thrombospondinfragmente und deren verwendung bei klinischen krebs-tests und der erzeugung von antikörpern und sonstigen bindungsmitteln | |
Gu et al. | An evaluation of direct PCR assays for the detection and quantification of Porphyromonas gingivalis | |
DE60144027D1 (de) | 5t4 rna in plasma und serum als marker für neoplastische erkrankungen | |
NO20054142D0 (no) | In vitro diagnostisk test for enterovirale infeksjoner | |
DE60309879D1 (de) | Verfahren zur Diagnose von Krebs | |
WO2003056341A3 (de) | Verfahren zur diagnose von brustkrebserkrankungen, zugehörige peptide und deren verwendungen |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |